DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j5b4m4/biosimilars) has announced the addition of the "Biosimilars - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. Annual estimates and forecasts are provided for the period 2008 through 2017.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Key Topics Covered
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Market Overview
2. Market Outlook
3. Market Trends
4. Market Dynamics
5. Market Drivers And Restraints
6. Competitive Scenario
7. Global Biologics Market
8. Product Overview
9. Product Approvals/Introductions
10. Product Approvals/Introductions - A Historic Perspective Builder
11. Corporate Initiatives In The Global Biosimilars Space
12. Strategic Corporate Developments - A Historic Perspective Builder
13. Focus On Select Market Players
14. Global Market Analytics
III. Market
1. The United States
2. Japan
3. Europe
4. Rest Of World
IV. Competitive Landscape
Companies Mentioned
The report profiles 55 companies including many key and niche players such as
- Biocon
- Biopartners
- Cipla
- Dr. Reddys Laboratories
- Hospira
- Intas Biopharmaceuticals
- Sandoz International
- Shantha Biotechnics
- Teva Pharmaceutical Industries
- Wockhardt
For more information visit http://www.researchandmarkets.com/research/j5b4m4/biosimilars